Long-acting beta2-agonists: comparative pharmacology and clinical outcomes.

about

Effects of asthma treatment: the present and future.Budesonide/formoterol combination in COPD: a US perspective.The preclinical toxicology of salmeterol hydroxynaphthoate.

P2860

Q37755242-AF728206-02A7-42CB-A1EF-FC1A496CBC6F Q37805343-BDDE881F-4F7E-4A27-93F9-8F981B748FA3 Q43134820-7EEBB8F4-28D4-4590-8363-527BC3D0DF6B

P2860

Long-acting beta2-agonists: comparative pharmacology and clinical outcomes.

Item

http://www.wikidata.org/entity/Q35627925

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Long-acting beta2-agonists: comparative pharmacology and clinical outcomes.

@ast

Long-acting beta2-agonists: comparative pharmacology and clinical outcomes.

@en

type

Item

label

Long-acting beta2-agonists: comparative pharmacology and clinical outcomes.

@ast

Long-acting beta2-agonists: comparative pharmacology and clinical outcomes.

@en

prefLabel

Long-acting beta2-agonists: comparative pharmacology and clinical outcomes.

@ast

Long-acting beta2-agonists: comparative pharmacology and clinical outcomes.

@en

P1476

Long-acting beta2-agonists: comparative pharmacology and clinical outcomes.

@en

P2093

Hanneke J van der Woude

http://www.w3.org/2001/XMLSchema#string

René Aalbers

http://www.w3.org/2001/XMLSchema#string

P2860

Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells

Formoterol compared with beclomethasone and placebo on allergen-induced asthmatic responses

Comparative study of extended release albuterol sulfate and long-acting inhaled salmeterol xinafoate in the treatment of nocturnal asthma

A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaler with albuterol metered-dose inhaler.

Comparison between formoterol 12 microg b.i.d. and on-demand salbutamol in moderate persistent asthma.

Are asthma medications and management related to deaths from asthma?

Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial.

Salmeterol enhances the inhibitory activity of dexamethasone on allergen-induced blood mononuclear cell activation.

The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease

Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality?

P2888

bf03257163

P304

55-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/BF03257163

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14720076

http://www.w3.org/2001/XMLSchema#string

Long-acting beta2-agonists: comparative pharmacology and clinical outcomes.

about

P2860

P2860

Long-acting beta2-agonists: comparative pharmacology and clinical outcomes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698